Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-Related Macular Degeneration (ARMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT04697095
What this trial is testing

Survival of Monocytes Collected From Patients With Atrophic AMD in Retinal Pigmented Epithelium Explants

Who this might be right for
Age Related Macular Degeneration
Hospices Civils de Lyon 80
Testing effectiveness (Phase 2)Study completedNCT06664502
What this trial is testing

A 2-part Study Consisting of a Multiple Ascending Dose Safety Study in Participants With Macular Edema Following Branch Retinal Vein Occlusion and a Dose-finding Safety and Preliminary Efficacy Study in Participants With Either Diabetic Macular Edema or Neovascular Age-related Macular Degeneration

Who this might be right for
Diabetic Macular Edema (DME)Neovascular Age-related Macular Degeneration (NVAMD)BRVO - Branch Retinal Vein Occlusion
EyeBiotech Ltd. 38
Testing effectiveness (Phase 2)Study completedNCT00220805
What this trial is testing

Use of Immune Globulin Intravenous (Human) To Treat Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
Grifols Therapeutics LLC 96
Very early researchLooking for participantsNCT07145008
What this trial is testing

Suprachoroidal Triamcinolone in Macular Edema for Patients With Non-Infectious Uveitis Resistant to Subtenon Triamcinolon

Who this might be right for
Macular Edema (ME)Non Infectious Uveitis
University of Baghdad 20
Not applicableEnded earlyNCT03105609
What this trial is testing

Enhancing the Lucentis (Ranibizumab) Management of Choroidal Neovascular Membranes With Hyperspectral Imaging

Who this might be right for
Macular DegenerationChoroidal Neovascularization
Center for Eye Research Australia 4
Not applicableStudy completedNCT05961332
What this trial is testing

COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Geographic Atrophy

Who this might be right for
Macular Degeneration, Age RelatedGeographic Atrophy
University of Wisconsin, Madison 62
Large-scale testing (Phase 3)Study completedNCT03034772
What this trial is testing

Dorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular DegenerationWet Macular Degeneration
Wills Eye 52
Not applicableStudy completedNCT00708929
What this trial is testing

Does Complement Factor H Gene Polymorphism Play a Role in the Regulation of Vascular Tone in the Choroid?

Who this might be right for
Genetic PolymorphismMacular DegenerationRegional Blood Flow+1 more
Medical University of Vienna 100
Not applicableStudy completedNCT02395757
What this trial is testing

Microperimetry and Eye Progressing From Stage 3 to Stage 4 Age-related Macular Degeneration (AMD)

Who this might be right for
Stage 3 Age Related Macular Degeneration (AREDS Classification)
Hospices Civils de Lyon 182
Large-scale testing (Phase 3)UnknownNCT02296567
What this trial is testing

Comparison of Pharmacokinetics of and Effect on Systemic VEGF Levels in Age Related Macular Degeneration Patients

Who this might be right for
Age Related Macular Degeneration
East Florida Eye Institute 80
Large-scale testing (Phase 3)Study completedNCT00042211
What this trial is testing

Preventing Depression in Patients With Macular Degeneration

Who this might be right for
DepressionMacular Degeneration
Thomas Jefferson University 206
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07557121
What this trial is testing

Safety and Efficacy of AIV007 Periocular Injection in Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular (Wet) Age-Related Macular Degeneration
AiViva BioPharma, Inc. 35
Testing effectiveness (Phase 2)Study completedNCT00435539
What this trial is testing

Compare Multiple Doses Intravitreal Microplasmin for Treatment of Patients With Vitreomacular Traction (MIVI-IIt)

Who this might be right for
Vitreomacular Traction
ThromboGenics 60
Large-scale testing (Phase 3)Active Not RecruitingNCT05461339
What this trial is testing

TAB014 Compared to Lucentis® in Patients with Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
BioDlink Biopharm Co., Ltd. 488
Post-approval studies (Phase 4)Study completedNCT01315275
What this trial is testing

A Clinical Study in Current Medical Practice of the Efficacy and Safety of Ranibizumab 0.5mg in Diabetic Patients Presenting a Visual Impairment Due to Macular Edema

Who this might be right for
Visual ImpairmentMacular Edema
Novartis Pharmaceuticals 394
Large-scale testing (Phase 3)Study completedNCT00000167
What this trial is testing

Complications of Age-Related Macular Degeneration Prevention Trial

Who this might be right for
Macular Degeneration
National Eye Institute (NEI) 1,052
Large-scale testing (Phase 3)Temporarily pausedNCT00460967
What this trial is testing

Safety and Effectiveness Investigation for Dry, Non-Exudative Age Related Macular Degeneration (AMD) Using Rheopheresis

Who this might be right for
Age-Related Maculopathy
OccuLogix 325
Not applicableLooking for participantsNCT05355415
What this trial is testing

Adaptive Optics Imaging of Outer Retinal Diseases

Who this might be right for
Retinal DegenerationAge-Related Macular DegenerationRetinitis Pigmentosa+7 more
Food and Drug Administration (FDA) 100
Early research (Phase 1)Ended earlyNCT00102115
What this trial is testing

Study of Talaporfin Sodium Photodynamic Therapy to Treat Advanced Age Related Macular Disease

Who this might be right for
Macular DegenerationChoroidal Neovascularization
Light Sciences LLC 27
Not applicableStudy completedNCT05082415
What this trial is testing

Real-world Evaluation of Brolucizumab for the Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD) (IRIS Study)

Who this might be right for
Age-related Macular Degeneration (AMD)
Novartis Pharmaceuticals 9,456
Next Page